What is NDC 51662-1584?

51662-1584 is the product NDC for Dextrose monohydrate, Dextrose monohydrate 25 g/50mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dextrose monohydrate?

2 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dextrose monohydrate NDC 51662-1584

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1584Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1584Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1584-1	5166215840151662158401	1 SYRINGE in 1 CARTON (51662-1584-1) / 50 mL in 1 SYRINGEMarketed from Feb 11, 2022
51662-1584-3	5166215840351662158403	10 POUCH in 1 CASE (51662-1584-3) / 1 SYRINGE in 1 POUCH (51662-1584-2) / 50 mL in 1 SYRINGEMarketed from Feb 11, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dextrose monohydrate
Generic name (nonproprietary): dextrose monohydrate
Active ingredients: Dextrose monohydrate — 25 g/50mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203451
Marketing start: Feb 11, 2022
Listing expires: Dec 31, 2026
Identifiers: Product ID 51662-1584_11ff2610-3e97-79d1-e063-6294a90a6412SPL ID 11ff2610-3e97-79d1-e063-6294a90a6412SPL set ID d7c4f9eb-9b89-c5a3-e053-2a95a90a28a2RxCUI 727517UNII LX22YL083G

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662158401 followed by a unit qualifier and the quantity

Package 51662-1584-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 22, 2024.

Indications (excerpt from the label)

INDICATIONS & USAGE 50% Dextrose Injection is indicated in the treatment of insulin hypoglycemia (hyperinsulinemia or insulin shock) to restore blood glucose levels. The solution is also indicated, after dilution, for intravenous infusion as a source of carbohydrate calories in patients whose oral intake is restricted or inadequate to maintain nutritional requirements. Slow infusion of hypertonic solutions is essential to ensure proper utilization of dextrose and avoid production of hyperglycemia.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1584

What is NDC 51662-1584?: 51662-1584 is the product NDC for Dextrose monohydrate, Dextrose monohydrate 25 g/50mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dextrose monohydrate.
What is the active ingredient?: Dextrose monohydrate.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dextrose monohydrate?: 2 other product NDCs are listed under this name. See all Dextrose monohydrate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dextrose monohydrate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dextrose Monohydrate	Dextrose monohydrate 25 g/50mL	Injection, SolutionIntravenous	Medical Purchasing Solutions, LLC	71872-7282	71872-7282-01
Dextrose Monohydrate	Dextrose monohydrate 25 g/50mL	Injection, SolutionIntravenous	International Medication Systems, Limited	76329-3302	76329-3302-01

Other NDCs under ANDA 203451

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203451
Product	Strength	Form · route	Labeler	Product NDC
Dextrose Monohydrate	Dextrose monohydrate 25 g/50mL	Injection, SolutionIntravenous	Medical Purchasing Solutions, LLC	71872-7282
Dextrose Monohydrate	Dextrose monohydrate 25 g/50mL	Injection, SolutionIntravenous	International Medication Systems, Limited	76329-3302